https://www.avient.com/resource-center?document_type=0&industry=0&product_family=84&product_subfamily=0&product_name=0&op=FILTER RESULTS&form_build_id=form-fNS88LG3BRw1MCsEhxqrGzoCcCISeOxlsDfIOUV4Mx0&form_id=resource_filter_form&page=0
Medical Grade Colorants and Additives for Wearable Medical Devices
Discover more about Avient medical grade colorant and additives for wearable medical devices.
OnColor™ REC Polymer Colorants provided this fiber manufacturer a PCF calculation to help in meeting sustainability targets
https://www.avient.com/idea/navigating-challenges-semiconductor-packaging-specialty-polymer-solutions
Silicon wafers and semiconductors are essential for creating electronic chips used in many modern technologies, such as phones, watches, cars, medical devices, and more.
These technologies rely on semiconductors to process data and provide cloud computing power.
This has boosted demand for silicon wafers and semiconductors used in servers, storage devices, and networking equipment.
https://www.avient.com/resource-center?document_type=0&industry=0&product_family=84&product_subfamily=0&product_name=0&op=FILTER RESULTS&form_build_id=form-fNS88LG3BRw1MCsEhxqrGzoCcCISeOxlsDfIOUV4Mx0&form_id=resource_filter_form
Medical Grade Colorants and Additives for Wearable Medical Devices
Discover more about Avient medical grade colorant and additives for wearable medical devices.
OnColor™ REC Polymer Colorants provided this fiber manufacturer a PCF calculation to help in meeting sustainability targets
https://www.avient.com/resource-center?document_type=0&form_build_id=form-fNS88LG3BRw1MCsEhxqrGzoCcCISeOxlsDfIOUV4Mx0&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=84&product_name=0&product_subfamily=0&page=0
Medical Grade Colorants and Additives for Wearable Medical Devices
Discover more about Avient medical grade colorant and additives for wearable medical devices.
OnColor™ REC Polymer Colorants provided this fiber manufacturer a PCF calculation to help in meeting sustainability targets
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
Mevopur™ Healthcare Bio-based Polymer Solutions
for Medical Devices and Pharmaceutical Packaging
Manufacturers of medical devices and
pharmaceutical packaging are increasingly faced
with the challenge of integrating sustainability into
the design of their products.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.
https://www.avient.com/sites/default/files/2022-04/Avient Announces Agreement to Acquire Dyneema_0.pdf
Examples include:
• Unique technologies that improve the recyclability of products and enable recycled content
to be incorporated, thus advancing a more circular economy
• Light-weighting solutions that replace heavier traditional materials like metal, glass and
wood, which can improve fuel efficiency in all modes of transportation and reduce carbon
footprint
• Sustainable infrastructure solutions that increase energy efficiency, renewable energy,
natural resource conservation and fiber optic / 5G network accessibility
Avient employs approximately 8,700 associates and is certified ACC Responsible Care®, a
founding member of the Alliance to End Plastic Waste and certified Great Place to Work®.
Factors that could cause
actual results to differ materially from those implied by these forward-looking statements include,
but are not limited to: the time required to consummate the acquisition of the Dyneema business;
the satisfaction or waiver of conditions in the purchase agreement; completion of the consultation
process with the relevant Dutch works council; the ability to obtain required regulatory or other
third-party approvals and consents and otherwise consummate the proposed acquisition of the
Dyneema business; our ability to achieve the strategic and other objectives relating to the
proposed acquisition of the Dyneema business and possible sale of the distribution business;
disruptions, uncertainty or volatility in the credit markets that could adversely impact the
availability of credit already arranged and the availability and cost of credit in the future; the effect
on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory
risks; the current and potential future impact of the COVID-19 pandemic on our business, results
of operations, financial position or cash flows; changes in polymer consumption growth rates and
laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations
in raw material prices, quality and supply, and in energy prices and supply; production outages
or material costs associated with scheduled or unscheduled maintenance programs;
unanticipated developments that could occur with respect to contingencies such as litigation and
environmental matters; an inability to raise or sustain prices for products or services; information
systems failures and cyberattacks; and other factors affecting our business beyond our control,
including without limitation, changes in the general economy, changes in interest rates and
changes in the rate of inflation.
The Company does not provide reconciliations of forward-looking non-GAAP financial measures,
such as outlook for adjusted EBITDA, to the most comparable GAAP financial measures on a
forward-looking basis because the Company is unable to provide a meaningful or accurate
calculation or estimation of reconciling items and the information is not available without
unreasonable effort.
https://www.avient.com/news/polyone-design-and-innovation-solutions-take-center-stage-chinaplas-2019
This new addition to CHINAPLAS includes a display area called CMF (color, material, finish) Walls, a Design Forum where presenters will discuss sustainability, and finally a Designers' Night networking event.
In addition to the CMF Inspiration Walls, PolyOne will speak at the CMF Design Forum and Designers' Night networking event during CHINAPLAS.
Polymer Distribution Solutions for Healthcare take the guesswork out of material selection for medical devices by offering a broad portfolio of solutions that meet diverse requirements.
https://www.avient.com/news/medtec-china-2024-avient-announces-healthcare-tpu-manufacturing-expansion
Additionally, Avient’s ISO 13485 manufacturing site in Singapore for its Mevopur™ formulations recently achieved ISO/IEC 17025 accreditation for Biological Evaluation of Medical Devices–Part 5: Tests for In-Vitro Cytotoxicity.
Cesa™ Low Retention Additives for Healthcare: formulations that can repel water and other liquids that deliver the last drop out of a package or devices such as pipette tips to change surface retention performance and enable fast evacuation.
Sustainable infrastructure solutions that increase energy efficiency, renewable energy, natural resource conservation and fiber optic / 5G network accessibility
https://www.avient.com/investor-center/news/avient-updates-third-quarter-and-full-year-2022-forecast
Sustainable infrastructure solutions that increase energy efficiency, renewable energy, natural resource conservation and fiber optic / 5G network accessibility
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; the ability to obtain required regulatory approvals and otherwise consummate the proposed sale of the Distribution business; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions.
The Company does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for adjusted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort.
https://www.avient.com/sites/default/files/2023-01/Mevopur Colorants _ Additives Brochure.pdf
Mevopur color and performance concentrates as
well as ready-to-use formulations add value to a
wide range of applications:
MEDICAL DEVICES
• Drug delivery
• Catheters
• Renal care/dialysis
• Surgical instruments
• Dental instruments
• Medical device packaging
• Electronic instruments and accessories
for monitoring
PHARMACEUTICAL PACKAGING
• Vials, ampoules
• Bottles for pills, liquid medicines
• Blister packaging
IN VITRO DIAGNOSTICS (IVD)
• Blood analysis
• IVD devices
• IVD disposables (e.g., pipette tips)
• Point-of-Care
To meet various manufacturing processes,
colorants and functional additives are provided
as concentrates for dilution into the polymer or
as ready-to-use formulations.
The cycle
time in injection molding can be reduced (10–15%
in PP) to support higher output and less energy
consumption.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.